Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

484 ! Wed, 8/1/2018, 8:30 AM - 10:20 AM CC-West 121
Clinical Trial Design- 5 — Contributed Papers
Biopharmaceutical Section
Chair(s): Jane Qian, Abbvie
8:35 AM Moving Beyond Longrank/Hazard Ratio Test/Estimation Approach in Cancer Clinical Trials
Hajime Uno, Dana Farber Cancer Institute; Miki Horiguchi, Kitasato University
8:50 AM Sample Size Allocation in Multi-Regional Equivalence Studies

Jason Liao, Merck & Co. Inc.; Ziyi Yu, Jazz Pharmaceuticals Inc; Yulan Li, Myovant Sciences

Chien-Hua Wu, Chung-Yuan Christian University; Shu-Mei Wan, Lunghwa University of Science and Technology
9:20 AM A Model-Based Approach for Simulating Adaptive Clinical Studies with Surrogate Endpoints Used for Interim Decision-Making

Xiaotian Chen, AbbVie; Alan Hartford, AbbVie Inc; Mei Li, AbbVie; Jun Zhao, AbbVie
9:35 AM A Curtailed Two-Stage Selection and Testing Procedure for Comparative Clinical Trials

Mingyue Wang, Syracuse University; Pinyuen Chen, Syracuse University
9:50 AM Longitudinal Parametric Dose-Response Surface Model Assisted Early Phase Study Design

Yongming Qu, Eli Lilly and Company
10:05 AM Assessment of Treatment Effect on Overall Survival in the Presence of Treatment Switching: a Bridging Approach Across Various Modeling Methods

Yiyun Tang, Pfizer, Inc.; Selaru Paulina, Pfizer Inc.; Xin Huang, Pfizer Inc.